Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Nov 18, 2025 · Filed Nov 19, 2025
The CEO of Sensus Healthcare paid $101K out of pocket for Sensus Healthcare shares. 2 other people at Sensus Healthcare bought some too, in the same month.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$100,750
Shares × reported transaction price
$100K–$500K
+2.1%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
Not enough history to judge
Confirmed open-market purchases by the same insider in the available history
3 distinct insiders in 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
This purchase equals about 8% of the CEO's reported total pay for fiscal 2024 ($1.26M)
Purchase value ÷ the CEO's total from the Summary Compensation Table, as tagged in the pay versus performance table of the company's proxy statement (DEF 14A), filed 2025-04-29. The proxy names Mr. J Sardano as CEO for that year. A size comparison, not a judgement
12 days after results of Nov 6, 2025, 86 days before results of Feb 12, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $4.04 on Nov 18, 2025, 31% above its 52-week low and 55% below its high, after a 14% rise over the previous 30 trading days
52-week range $3.09 (Sep 17, 2025) to $8.99 (Feb 5, 2025), 16% of the way up, from 250 adjusted closes. 30 trading days earlier: $3.55 on Oct 7, 2025. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
3 SRTS insiders bought within the same week. That happened once before in filings since 2016: May 2023. The largest open-market purchase by any SRTS insider in filings since 2016. Joseph C Sardano's largest purchase of SRTS in their filings since 2023
Compared with every open-market purchase and sale of this company in SEC filings since 2006. A fact about the record, not a signal to trade
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +6.6% | +4.7% | +1.9% |
| 30 days | −3.0% | +5.0% | −8.0% |
| 90 days | −2.0% | +5.2% | −7.2% |
| 180 days | −14.8% | +12.4% | −27.2% |
Past results only. Not a forecast.
Insider filing
Traded Dec 12, 2025 · filed 4 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider buying
3 insiders in a week, 2nd time since 2016Traded Nov 21, 2025 · filed the same day
A Sensus Healthcare director paid $28K out of pocket for Sensus Healthcare shares. 2 other people at Sensus Healthcare bought some too, in the same month. Shares held went up 5% with this purchase.
Insider buying
Their first buy on recordTraded Nov 13, 2025 · filed 7 days later
A Sensus Healthcare director paid $11K out of pocket for Sensus Healthcare shares. 2 other people at Sensus Healthcare bought some too, in the same month.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.